Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms

Overview

Journal Mov Disord Clin Pract

Publisher Wiley

Specialty Neurology

Date 2022 Jan 10

PMID 35005060

Authors

Cecilia Peralta

Antonio P Strafella

Thilo van Eimeren

Roberto Ceravolo

Klaus Seppi

Valtteri Kaasinen

Julieta E Arena

Stephane Lehericy

Affiliations

Soon will be listed here.

Abstract

Background: Rapid advances in neuroimaging technologies in the exploration of the living human brain also apply to movement disorders. However, the accurate diagnosis of Parkinson's disease (PD) and atypical parkinsonian disorders (APDs) still remains a challenge in daily practice.

Methods: We review the literature and our own experience as the Movement Disorder Society-Neuroimaging Study Group in Movement Disorders with the aim of providing a practical approach to the use of imaging technologies in the clinical setting.

Results: The enormous amount of articles published so far and our increasing recognition of imaging technologies contrast with a lack of imaging protocols and updated algorithms for differential diagnosis. The distinctive pathological involvement in different brain structures and the correlation with imaging findings obtained with magnetic resonance, positron emission tomography, or single-photon emission computed tomography illustrate what qualitative and quantitative measures may be useful in the clinical setting.

Conclusion: We delineate a pragmatic approach to discuss imaging technologies, updated imaging algorithms, and their implications for differential diagnoses in PD and APDs.

Citing Articles

Cross-modality PET image synthesis for Parkinson's Disease diagnosis: a leap from [F]FDG to [C]CFT.

Shen Z, Wang J, Huang H, Lu J, Ge J, Xiong H Eur J Nucl Med Mol Imaging. 2025; 52(4):1566-1575.

PMID: 39828866 DOI: 10.1007/s00259-025-07096-3.

Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directions.

Quattrone A, Zappia M, Quattrone A Front Neurol. 2024; 15:1460576.

PMID: 39364423 PMC: 11446779. DOI: 10.3389/fneur.2024.1460576.

Increased mean diffusivity of the caudal motor SNc identifies patients with REM sleep behaviour disorder and Parkinson's disease.

Alushaj E, Hemachandra D, Ganjavi H, Seergobin K, Sharma M, Kashgari A NPJ Parkinsons Dis. 2024; 10(1):128.

PMID: 38951528 PMC: 11217278. DOI: 10.1038/s41531-024-00731-0.

Exploring neurodegenerative disorders using advanced magnetic resonance imaging of the glymphatic system.

Prasuhn J, Xu J, Hua J, van Zijl P, Knutsson L Front Psychiatry. 2024; 15:1368489.

PMID: 38651012 PMC: 11033437. DOI: 10.3389/fpsyt.2024.1368489.

The new era of artificial intelligence in neuroradiology: current research and promising tools.

Carvalho Macruz F, Dias A, Andrade C, Penteado Nucci M, de Medeiros Rimkus C, Lucato L Arq Neuropsiquiatr. 2024; 82(6):1-12.

PMID: 38565188 PMC: 10987255. DOI: 10.1055/s-0044-1779486.

References

Fiford C, Ridgway G, Cash D, Modat M, Nicholas J, Manning E . Patterns of progressive atrophy vary with age in Alzheimer's disease patients. Neurobiol Aging. 2017; 63:22-32. PMC: 5805840. DOI: 10.1016/j.neurobiolaging.2017.11.002. View

Pavese N, Tai Y . Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism. Mov Disord Clin Pract. 2018; 5(2):131-140. PMC: 6174398. DOI: 10.1002/mdc3.12590. View

Schwarz S, Abaei M, Gontu V, Morgan P, Bajaj N, Auer D . Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. 2013; 3:481-8. PMC: 3830065. DOI: 10.1016/j.nicl.2013.10.006. View

Tinaz S, Courtney M, Stern C . Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord. 2011; 26(3):436-41. PMC: 4502575. DOI: 10.1002/mds.23453. View

Strafella A, Bohnen N, Perlmutter J, Eidelberg D, Pavese N, van Eimeren T . Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Mov Disord. 2017; 32(2):181-192. DOI: 10.1002/mds.26907. View

Tondo G, Esposito M, Dervenoulas G, Wilson H, Politis M, Pagano G . Hybrid PET-MRI Applications in Movement Disorders. Int Rev Neurobiol. 2019; 144:211-257. DOI: 10.1016/bs.irn.2018.10.003. View

Mangesius S, Hussl A, Krismer F, Mahlknecht P, Reiter E, Tagwercher S . MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP. Parkinsonism Relat Disord. 2017; 46:47-55. DOI: 10.1016/j.parkreldis.2017.10.020. View

Cho H, Choi J, Lee S, Ryu Y, Lee M, Lyoo C . F-AV-1451 binds to putamen in multiple system atrophy. Mov Disord. 2016; 32(1):171-173. DOI: 10.1002/mds.26857. View

Kaasinen V, Vahlberg T . Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies. Ann Neurol. 2017; 82(6):873-882. DOI: 10.1002/ana.25103. View

10.

Bajaj S, Krismer F, Palma J, Wenning G, Kaufmann H, Poewe W . Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis. PLoS One. 2017; 12(12):e0189897. PMC: 5747439. DOI: 10.1371/journal.pone.0189897. View

11.

Lehericy S, Vaillancourt D, Seppi K, Monchi O, Rektorova I, Antonini A . The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward. Mov Disord. 2017; 32(4):510-525. DOI: 10.1002/mds.26968. View

12.

Hoglinger G, Respondek G, Stamelou M, Kurz C, Josephs K, Lang A . Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017; 32(6):853-864. PMC: 5516529. DOI: 10.1002/mds.26987. View

13.

Heim B, Krismer F, Seppi K . Structural Imaging in Atypical Parkinsonism. Int Rev Neurobiol. 2018; 142:67-148. DOI: 10.1016/bs.irn.2018.08.010. View

14.

Prodoehl J, Li H, Planetta P, Goetz C, Shannon K, Tangonan R . Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov Disord. 2013; 28(13):1816-22. PMC: 3748146. DOI: 10.1002/mds.25491. View

15.

Ohtsuka C, Sasaki M, Konno K, Koide M, Kato K, Takahashi J . Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci Lett. 2013; 541:93-8. DOI: 10.1016/j.neulet.2013.02.012. View

16.

Adler C, Beach T, Hentz J, Shill H, Caviness J, Driver-Dunckley E . Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014; 83(5):406-12. PMC: 4132570. DOI: 10.1212/WNL.0000000000000641. View

17.

Vlaar A, van Kroonenburgh M, Kessels A, Weber W . Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 2007; 7:27. PMC: 2064928. DOI: 10.1186/1471-2377-7-27. View

18.

Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M . Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. JAMA Neurol. 2020; 77(11):1408-1419. PMC: 7341407. DOI: 10.1001/jamaneurol.2020.2526. View

19.

Drake-Perez M, Boto J, Fitsiori A, Lovblad K, Vargas M . Clinical applications of diffusion weighted imaging in neuroradiology. Insights Imaging. 2018; 9(4):535-547. PMC: 6108979. DOI: 10.1007/s13244-018-0624-3. View

20.

Taniguchi D, Hatano T, Kamagata K, Okuzumi A, Oji Y, Mori A . Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease. Mov Disord. 2018; 33(9):1488-1492. DOI: 10.1002/mds.27365. View